Slow study start-up and protocol amendments can be disruptive to a #ClinicalTrial.
Join a webinar on Thursday, 8 Oct and learn how @Veristat is using IBM Clinical Development in their #COVID19 vaccine trial: https://ibm.co/3izFO48 .pic.twitter.com/EFriGcfAJR
3:00 AM - 6 Oct 2020
0 replies
4 retweets
4 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.